
General Proximity
The next generation of induced-proximity medicines.
Topics
- Location
- San Francisco, CA, United States
- Team size
- 15 employees
- YC batch
- Winter 2020
- Status
- Active
- Stage
- Early stage

The next generation of induced-proximity medicines.
Hiring by function

What they do:
Artificial intelligence for drug discovery.
Quick facts:
HQ: San Francisco, CA, United States
Funding:
$19.8M · Equity · Mar 2026

What they do:
Arpeggio Bio develops drugs targeting transcription factors using AI…
Quick facts:
HQ: Boulder, CO, United States

What they do:
Discovering drugs that target the DNA regulome
Quick facts:
HQ: Seattle, WA, United States

What they do:
Using CRISPR to find treatments for cancer and inflammation
Quick facts:
HQ: San Francisco, CA, United States

What they do:
Multi-targeted therapeutics to treat complex diseases
Quick facts:
HQ: New York, NY, United States

What they do:
Adventris makes cancer vaccines
Quick facts:
HQ: Baltimore, MD, United States
The next generation of induced-proximity medicines.
San Francisco, CA, United States
15 employees, according to the company profile.
There are no funding rounds for General Proximity in our data.
Yes: 8 open roles on the company’s job board.
Similar startups: Numerion Labs, Arpeggio Bio, and Talus Bio.